DOCSLIB.ORG

Disparities in Age of Smoking Initiation and Transition to Daily Smoking in New Zealand

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Disparities in Age of Smoking Initiation and Transition to Daily Smoking in New Zealand Disparities in age of smoking initiation and transition to daily smoking in New Zealand September 2019 ISBN: 978-0-478-44986-0 Prepared for the Health Promotion Agency/Te Hiringa Hauora (HPA) by: Niveditha Gurram and Greg Martin, Research and Evaluation Unit, Health Promotion Agency. Citation: Gurram, N., & Martin, G. (2019). Disparities in age of smoking initiation and transition to daily smoking in New Zealand. Wellington: Health Promotion Agency. Copyright The copyright owner of this publication is HPA. HPA permits the reproduction of material from this publication without prior notification, provided that fair representation is made of the material and HPA is acknowledged as the source. This document is available at: http://www.hpa.org.nz/research-library/research-publications Any queries regarding this report should be directed to HPA at the following address: Health Promotion Agency PO Box 2142 Wellington 6140 New Zealand www.hpa.org.nz [email protected] September 2019 CONTENTS Executive summary 5 Acknowledgements 7 1. Introduction 8 1.1 Background 8 1.2 Current study Objectives 9 2. Methods 9 2.1 Survey 9 2.2 Variables 9 2.3 Analyses 10 3. Results 11 3.1 Age of smoking initiation 11 3.2 Age of daily uptake of smoking 12 3.3 Transition duration from smoking initiation to daily uptake 13 4. Discussion 14 4.1 Strengths 15 4.2 Limitations 15 5. Conclusion 16 6. References 17 Appendix: Trends in the age of smoking initiation and daily uptake 2010-2018 19 List of Tables Table 1: 2018 HLS sample characteristics 11 Table 2: Mean age (in years) of smoking initiation among ever smokers who participated in the 2018 HLS 12 Table 3: Mean age of daily uptake of smoking and transition duration (in years) among ever daily smokers who participated in the 2018 HLS 13 Table 4: Unadjusted mean age (in years) of smoking initiation among ever smokers, 2010- 2018 19 Table 5: Unadjusted mean age (in years) of smoking daily uptake among ever daily smokers, 2010-2018 20 Table 6: Unadjusted mean transition age (in years) from smoking initiation to daily uptake of smoking among ever daily smokers, 2010-2018 21 EXECUTIVE SUMMARY INTRODUCTION Understanding trends and disparities related to the age of smoking initiation and transition to daily smoking is important for monitoring the progress of tobacco control strategies. The purpose of this study was to examine the age of smoking initiation and transition into daily smoking using a nationally representative sample of New Zealanders aged 15 years and over by age, sex, ethnicity and deprivation status. This study also compares these results over time. METHODS The Health and Lifestyles Survey (HLS) is a biennial survey of New Zealand adults aged 15 years and over. The survey used multistage, stratified, clustered and random probability sampling and collected information through computer assisted face to face in-house personal interviews. The HLS was completed by 2,725 participants in 2018. KEY FINDINGS In 2018, the mean ages of smoking initiation and daily uptake were 15.3 years and 17.6 years respectively. Māori (14.1 years) and current smokers (14.8 years) were more likely to start smoking at a younger age. Males (15.3 years) were more likely to start smoking at a younger age when compared to females (16.1 years). Māori (16.7 years) were more likely to take up daily smoking at a younger age. Pasifika and Asian people were less likely to initiate first and daily smoking at a younger age. The mean transition duration from smoking initiation to daily uptake was 2.5 years for all smokers, although only 1.4 years for Asian people. Overall, there has been no significant increase in the mean age of smoking initiation between 2012 and 2018, and there has been no significant increase in mean age of uptake of daily smoking between 2010 and 2018. In 2018, Pasifika people were more likely to start smoking and take up daily smoking at a later age when compared to Pasifika people in 2012 and 2010 respectively. DISCUSSION Generally, smoking uptake occurs during adolescence. Despite the changing regulatory environment with regard to tobacco control the mean age of smoking initiation and daily uptake are still under 18 years. We found significant disparities in the age of smoking initiation and daily uptake among the predominant ethnic groups in New Zealand. Māori are initiating smoking and becoming daily smokers at a younger age than the general population. To achieve the Government’s ‘Smokefree 2025’ goal, it is important that policy makers and practitioners are aware of this age disparity in order to ensure this priority population is appropriately engaged. ACKNOWLEDGEMENTS The authors would like to thank the HLS participants for taking the time and effort to answer the questionnaire. We would also like to thank CBG Health Research Ltd for conducting the pilot testing of the questionnaire and undertaking the fieldwork. We also acknowledge Sarah Rendall for managing the HLS with the support of Denise Grealish and for the work she undertook with Wa Anwar to check and clean the data and Richard Ung for reviewing the analyses for this report. 1. INTRODUCTION 1.1 BACKGROUND In March 2011, the New Zealand (NZ) government set an aspirational goal of becoming smokefree by 2025, where less than 5% of the population smokes (The New Zealand Government, 2011). To achieve this goal it is important to understand and monitor the age of smoking initiation and transition into daily smoking. Internationally, there is substantial evidence that most smokers initiate smoking before the age of 18 (Everett et al., 1999; Giovino, 2002; U. S. Department of Health and Human Services, 2012). Several studies have shown that earlier onset smoking is strongly associated with future smoking behaviour and outcomes, including daily smoking, intensity of smoking, addiction to nicotine and difficulty in quitting (Everett et al., 1999; Fernandez et al., 1999; Reidpath, Ling, Wellington, Al- Sadat, & Yasin, 2012; Wilkinson, Schabath, Prokhorov, & Spitz, 2007). Understanding trends and disparities related to the age of smoking initiation and transition to daily smoking is important for monitoring progress of tobacco control strategies. Smoking prevalence in NZ has declined significantly over time. In 2018, 12.8% of adults (15 years or over) smoked daily compared to 16.8% in 2010. However, ethnic disparities continue to exist with 29.9% of Māori adults and 19.1% of Pasifika adults smoking daily (Health Promotion Agency, 2019a). In 2018, less than two percent of young people aged 14 and 15-years-old reported daily smoking, although rising to 5.2% of Māori and 2.9% of Pasifika (Action on Smoking and Health, 2018). In NZ, smoking initiation largely occurs among older youth and young adults (Edwards, Carter, Peace, & Blakely, 2013). Results from the 2012/13 New Zealand Health Survey show that Māori were earliest to initiate smoking at 14.1 years and Pasifika adults had the shortest transition time between initiation and daily uptake when compared with smokers of other ethnic groups (2.7 years) (Ministry of Health, 2014). There are weaknesses with the data available on age of smoking initiation and transition into daily smoking. Firstly, as gender and deprivation status are also associated with smoking prevalence (Tu, Newcombe, Edwards, & Walton, 2016), there is a lack of studies examining the age of smoking initiation and daily uptake by gender and deprivation status. Secondly, there are no further studies available monitoring these results across years. Given the decline in the smoking prevalence in NZ, more updated analyses of age of smoking initiation and daily uptake are required to determine where prevention initiatives might best be targeted. 1.2 CURRENT STUDY OBJECTIVES The aim of this paper is to explore the age of smoking initiation and transition into daily smoking using a nationally representative sample of New Zealanders aged 15 years and over (the 2018 Health and Lifestyles Survey, HLS). This study examines the mean age of smoking initiation and transition into daily uptake for adults as a whole and by age, gender, ethnicity, deprivation status and smoking status. This study also explores trends over time using data from previous waves of HLS data collection (2010, 2012 and 2016). 2. METHODS 2.1 SURVEY The 2018 HLS is a nationally representative survey of 2,725 New Zealanders aged 15 years and over. The survey used multistage, stratified, clustered and random probability sampling and collected information on various health related topics, including tobacco use, alcohol, gambling harm, health education, mental health, immunisation, skin cancer, nutrition and physical activity. Interviews were conducted face-to face in-house using Computer Assisted Personal Interviewing (CAPI). The unweighted response rate for the 2018 HLS is 75%. A full description of the 2018 HLS methodology can be found on the HPA website (Health Promotion Agency, 2018). Participation in the 2018 HLS was voluntary and informed consent was obtained. Ethics approval for the 2018 HLS was obtained from the New Zealand Ethics Committee (Application Number: 2018_15). To compare the results over time, we also used the data from 2010, 2012 and 2016 HLS. Fully detailed methodology reports for each survey year are available elsewhere (Devlin, 2011; Health Promotion Agency, 2013, 2017). 2.2 VARIABLES 2.2.1 Smoking status All survey participants were asked whether they had ever smoked a cigarette (even just a few puffs). Participants who answered ‘yes’ were classified as ever smokers and those who answered ‘no’ were classified as non-smokers. All ever smokers were asked whether they had smoked daily for a week. Those who answered ‘yes’ were categorised as ever daily smokers. All ever smokers were asked how often they smoke tobacco now.
Load more

Recommended publications
  • THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association
    THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association CONTENTS This Issue in the Journal 4 A summary of the original articles featured in this issue Editorials 6 Array of hope for high-resolution genetic screening services in New Zealand Christine M Morris, Ursula R Jewell 12 Toward more uniform conflict disclosures: the updated ICMJE conflict of interest reporting form International Committee of Medical Journal Editors (ICMJE) Original Articles 15 Taking the pulse: medical student workforce intentions and the impact of debt William R G Perry, Tim J Wilkinson 24 Programmatic research in medical education: a national collaboration Tim J Wilkinson, Jennifer M Weller, Judy McKimm, Barbara J O’Connor, Ralph E Pinnock, Phillippa J Poole, Dale Sheehan, Mike J Tweed, Andy M Wearn 34 The New Zealand Advanced Choice of Employment (ACE) Scheme: analysis after 7 years of District Health Board cooperation in a competitive employment context Brandon M Adams, Gregory O'Grady, J Richard Pole 43 The student code: ethical and professional expectations of medical students at the University of Otago Lynley C Anderson, Neil J Pickering Review Article 50 Array comparative genomic hybridisation: a new tool in the diagnostic genetic armoury Renate Marquis-Nicholson, Salim Aftimos, Ian Hayes, Alice George, Donald R Love Clinical Correspondence 62 A rare late complication of spilled gallstones Dinuk L Gooneratne NZMJ 16 July 2010, Vol 123 No 1318; ISSN 1175 8716 Page 1 of 112 URL: http://www.nzma.org.nz/journal/123-1318/4226/ ©NZMA 67 Apical pulmonary lesions due to Marfan syndrome misdiagnosed as pulmonary tuberculosis Prem P Gupta, Krishan B Gupta, Joginder S Gulia, Rohtas Yadav, Sanjeev Kumar, Dipti Agarwal 73 Nontraumatic hepatic hematoma caused by Wegener’s granulomatosis: an unusual cause of abdominal pain Selim Doganay, Ercan Kocakoc, Mehtap Balaban 79 Medical image.
    [Show full text]
  • Projecting Future Smoking Prevalence to 2025 and Beyond in New
    NEW ZEALAND MEDICAL JOURNAL http://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2014/vol-127-no-1406/6374 ORIGINAL ARTICLE Projecting future smoking prevalence to 2025 and beyond in New Zealand using smoking prevalence data from the 2013 Census Frederieke S van der Deen, Takayoshi Ikeda, Linda Cobiac, Nick Wilson, Tony Blakely Abstract Background We have previously published a forecasting model of future smoking prevalence in New Zealand (NZ). Under business-as-usual (BAU) assumptions NZ’s smokefree 2025 goal was not attained by any demographic group. However, the 2013 Census (which included a question on smoking) showed a greater than expected fall in prevalence, especially for Māori. We therefore aimed to provide upgraded projections to inform policy around tobacco endgame planning. Method The previously developed dynamic forecasting model was re-specified using smoking prevalence data from the 2006 and 2013 censuses from NZ. Calculations included changes in initiation by age 20 years, and net annual cessation rates, by sex, age, and ethnicity (Māori vs non-Māori). Projections under 2006–2013 trends (adjusted for no tax rises since 2010), by sex and ethnicity were made out to 2025 and beyond. Results Between the 2006 and 2013 censuses (adjusted for no tax rises since 2010), initiation of daily smoking by age 20 years decreased annually by 3.4% (95% uncertainty interval 3.2% to 3.6%) and 2.7% (2.5% to 2.8%) for non-Māori men and women, and by 2.9% (2.6% to 3.2%) and 3.2% (2.9% to 3.5%) for Māori respectively.
    [Show full text]
  • In the High Court of New Zealand Auckland Registry Civ-2002-404-1729
    IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY CIV-2002-404-1729 BETWEEN BRANDON POU AND KASEY POU Plaintiffs AND BRITISH AMERICAN TOBACCO (NEW ZEALAND) LIMITED AND W D & H O WILLS (NEW ZEALAND) LIMITED Defendants Hearing: 7-10, 13-17, 20-24, 27 & 28 February 2006, 8-10 and 13 March 2006 Appearances: Mr D B Collins QC, Mr B Corkill, Mr J French and Ms J Herschell for plaintiffs Mr M R Camp QC, Mr M R Bos, Mrs V Lobao and Mr S O'Sullivan for defendants Judgment: 3 May 2006 at 2 pm JUDGMENT OF LANG J Counsel: D B Collins QC, Lambton Chambers, 101 Lambton Quay, Wellington B Corkill, L 8, Central Chambers, 114-118 Lambton Quay, Wellington M R Camp QC, P O Box 10048, Wellington Ms J Herschell, P O Box 905, Wellington Solicitors: French Burt Partners, 110 Don Street, Invercargill Phillips Fox, P O Box 160, Auckland POU V BRITISH AMERICAN TOBACCO (NEW ZEALAND) LIMITED AND W D & H O WILLS (NEW ZEALAND) LIMITED HC AK CIV-2002-404-1729 [3 May 2006] TABLE OF CONTENTS Introduction [1] The claim [5] Issues [7] Summary of findings [8] 1. Is the plaintiffs’ claim barred by virtue of section 4(7) of the [10] Limitation Act 1950? Duty of Care [19] 2. Could any duty of care owed by a manufacturer of cigarettes in 1968 [20] include a duty to completely cease the manufacture and distribution of its products? 3. Was there a prima facie duty to warn consumers of the potential [30] hazards of cigarette smoking when Mrs Pou began smoking in 1968? If so, is the existence of the duty otherwise negated by virtue of the fact that the dangers of smoking were
    [Show full text]
  • Tobacco Control
    NEW ZEALAND HEALTH STRATEGY DHB TOOLKIT Tobacco Control To reduce smoking (and harm from second-hand smoke) 2001 Edition 1: October 2001 Contents Executive summary ...........................................................................................................3 Introduction........................................................................................................................4 Development of the toolkit .............................................................................................4 Key documents ..............................................................................................................4 Linkages.........................................................................................................................6 Policy context.....................................................................................................................7 The rationale for tobacco control in New Zealand .........................................................7 Who smokes in New Zealand? ......................................................................................9 Regional prevalence data ..............................................................................................9 Tobacco control efforts in New Zealand ......................................................................13 Roles and responsibilities for tobacco control .................................................................14 The Ministry of Health..................................................................................................14
    [Show full text]
  • The Tobacco Industry in NZ
    The Tobacco Industry in New Zealand: A Case Study of the Behaviour of Multinational Companies George Thomson Dr Nick Wilson Public Health Monograph Series No. 6 Department of Public Health Wellington School of Medicine and Health Sciences February 2002 2 Copyright All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the authors Public Health Monograph Series No. 6 ISSN 1175 - 7817 ISBN 0 - 473 - 08415 - 5 (Paper version) ISBN 0 - 473 - 08414 - 7 (Electronic version) Published by the Department of Public Health Wellington School of Medicine and Health Sciences PO Box 7343 Wellington South Wellington New Zealand Electronic version at: http://www.wnmeds.ac.nz/academic/dph/docs.htm “If you want to do something about malaria, you have to study mosquitoes. And if you want to do something about lung cancer, you have to study the tobacco industry.” Professor Stan Glantz. In: Noah T. Funding of study of tobacco firms is periled in House. The Wall Street Journal 7 August 1995. 3 The tobacco industry and its allies said it: “... nicotine is addictive. We are, then, in the business of selling nicotine, ….” (Addison Yeaman, Brown & Williamson vice president and general counsel, 1963. Cited in Lewan 1998) “Today’s teenager is tomorrow’s potential regular customer, and the overwhelming majority of smokers first begin to smoke while in their teens … The smoking patterns of teenagers are particularly important to Philip Morris ...” (1981 report sent from researcher Myron E Johnston to Robert B Seligman, then vice president of research and development at Philip Morris in Richmond, Virginia.
    [Show full text]
  • After the Smoke Has Cleared: Evaluation of the Impact of a New Smokefree Law
    After the Smoke has Cleared: Evaluation of the Impact of a New Smokefree Law A Report Commissioned and Funded by the New Zealand Ministry of Health ` Editorial team Advisory Group 8 Richard Edwards 1 * Shane Allwright 9 Chris Bullen 2 John Britton 10 Des O’Dea 1 Becky Freeman 2 Heather Gifford 3 Hayden McRobbie 11 Marewa Glover 4 Leigh Sturgiss 2 Murray Laugesen 5 Yannan Xiang George Thomson 1 Anaru Waa 6 Nick Wilson 1 Alistair Woodward 7 *Corresponding author: [email protected] 1. Department of Public Health, Wellington School of Medicine and Health Sciences, University of Otago 2. Clinical Trials Research Unit, School of Population Health, University of Auckland 3. Whakauae Research Services, Whanganui 4. Auckland Tobacco Control Research Centre, School of Population Health, University of Auckland 5. Health New Zealand Ltd, Christchurch 1 6. Health Sponsorship Council Research and Evaluation Unit, Wellington 7. School of Population Health, University of Auckland 8. Department of Public Health and Primary Care, Trinity College Centre for Health Sciences, Dublin, Ireland 9. Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK 10. ASH New Zealand, Auckland 11. New Zealand Drug Foundation, Wellington 2 Contents Contents 3 Acknowledgements 6 Executive summary 8 1. Introduction, scope and approach to the evaluation of the Smoke-free Environments Act Amendment 16 Summary 16 1.1. Introduction 16 1.2. Scope of the evaluation 17 1.3. Approaches to policy evaluation 17 1.4. Evaluation approach adopted in this report 18 1.5. Models of evaluation for tobacco control interventions 19 2. The Smoke-free Environments Act (1990) and Smoke-free Environments Amendment Act (2003) 20 Summary 20 2.1.
    [Show full text]
  • Illicit Tobacco in New Zealand, 2018 Full Year Report
    Illicit tobacco in New Zealand 2018 Full Year Report 24 May 2019 ______ kpmg.com/uk KPMG LLP Tel +44 (0)20 7311 1000 Strategy Group Fax +44 (0)20 7311 3311 15 Canada Square DX 157460 Canary Wharf 5 Canary Wharf London E14 5GL United Kingdom 24 May 2019 Important notice This presentation of key findings (the ‘Report’) has been prepared by KPMG LLP in the UK (‘KPMG UK’) for Philip Morris (New Zealand) Limited and Imperial Tobacco New Zealand Limited, described together in this Important Notice and in this Report as the ‘Beneficiary’, on the basis set out in a private contract dated 18th December 2018 agreed separately with the Beneficiaries. Nothing in this Report constitutes legal advice. Information sources, the scope of our work, and scope and source limitations, are set out in the Appendices to this Report. The scope of our review of the contraband, counterfeit and unbranded segments of the tobacco market within New Zealand was fixed by agreement with the Beneficiaries and is set out in the Appendices. We have satisfied ourselves, so far as possible, that the information presented in this Report is consistent with our information sources but we have not sought to establish the reliability of the information sources by reference to other evidence. This Report has not been designed to benefit anyone except the Beneficiaries. In preparing this Report we have not taken into account the interests, needs or circumstances of anyone apart from the Beneficiaries, even though we have been aware that others might read this Report. This Report is not suitable to be relied on by any party wishing to acquire rights or assert any claims against KPMG LLP (other than the Beneficiaries) for any purpose or in any context.
    [Show full text]
  • Smokefree-In-A-Box
    Smokefree-in-a-Box A Guide for Companies Going Smokefree INTRODUCTION Over the past 0 years, workplaces around the world have seen a sweeping movement towards smokefree air policies. Many companies have adopted smokefree policies voluntarily to protect workers and customers from the proven dangers of secondhand smoke. Other companies have created smokefree workplaces to comply with existing laws. Companies that have gone smokefree have found that these policies save money as well as lives. The policies also improve worker satisfaction and the company’s public image. The purpose of this toolkit is to help you design and implement a smokefree workplace. While there is no “one-size-fits-all” plan for going smokefree, this toolkit draws from the experience of workplaces around the world to provide the basic elements of an effective smokefree plan. This map shows the progress of smokefree policies worldwide as of March 008. Companies should adapt the advice in this toolkit to fit their unique circumstances. Experience from smokefree companies shows that proper implementation of these policies requires planning and coordination. This toolkit provides senior leadership, managers, and staff with easy- to-use advice on what to do from the moment your company decides to implement a smokefree policy. For more information on the Global Smokefree Partnership or on smokefree policies, please visit the Global Smokefree Partnership Web site at www.globalsmokefreepartnership.org or email [email protected]. This toolkit is a project of the Global Smokefree Partnership, a multi- partner initiative formed in 005 to promote effective smokefree air policies worldwide. The partnership involves more than 00 organizational and individual members from more than 60 countries worldwide, and it is hosted by the American Cancer Society and the Framework Convention Alliance.
    [Show full text]
  • New Zealand's Tobacco Control Programme 1985-1998
    Tobacco Control 2000;9:155–162 155 New Zealand’s tobacco control programme Tob Control: first published as 10.1136/tc.9.2.155 on 1 June 2000. Downloaded from 1985-1998 Murray Laugesen, Boyd Swinburn Abstract This paper reviews New Zealand’s national Objective—To review the impact of New tobacco control programme (TCP), asking Zealand’s tobacco control programme whether it has: (1) fulfilled its original aims and from 1985 to 1998 on smoking prevalence targets in reducing smoking; (2) achieved and tobacco consumption, and to estimate reductions in smoking among youth, Maori, the scope for further reduction. and lower income groups; (3) reduced Design—Country case study; interven- exposure to second hand smoke; (4) reduced tions, with outcomes ranked internation- cigarette mortality; and (5) made favourable ally across time. progress compared to other OECD (Organisa- Setting—New Zealand 1985-98; for 1985- tion for Economic Cooperation and Develop- 95, 23 OECD countries. ment) countries. Interventions—Between 1985 and 1998, This review begins in 1985, when the Minis- New Zealand eliminated tobacco advertis- ter of Health publicised a “comprehensive ing, halved the aVordability of cigarettes, policy to promote non-smoking” from his and reduced smoke exposure in work time advisory committee on smoking and health, by 39%. which asked the government to commit itself Main outcome measure—Reduction in to its TCP plan. The plan included public adult smoking prevalence and in tobacco involvement and health education, quit clinics products consumption
    [Show full text]
  • 2019 Full Year Report
    Illicit tobacco in New Zealand 2019 Full Year Report 26 May 2020 kpmg.com/uk KPMG LLP Tel +44 (0)20 7311 1000 Strategy Group Fax +44 (0)20 7311 3311 15 Canada Square DX 157460 Canary Wharf 5 Canary Wharf London E14 5GL United Kingdom 26 May 2020 Important notice This presentation of key findings (the ‘Report’) has been prepared by KPMG LLP in the UK (‘KPMG UK’) for Imperial Tobacco New Zealand Limited, described in this Important Notice and in this Report as the ‘Beneficiary’, on the basis set out in a private contract dated 1st August 2019 agreed separately with the Beneficiary. Nothing in this Report constitutes legal advice. Information sources, the scope of our work, and scope and source limitations, are set out in the Appendices to this Report. The scope of our review of the contraband, counterfeit and unbranded segments of the tobacco market within New Zealand was fixed by agreement with the Beneficiary and is set out in the Appendices. We have satisfied ourselves, so far as possible, that the information presented in this Report is consistent with our information sources but we have not sought to establish the reliability of the information sources by reference to other evidence. This Report has not been designed to benefit anyone except the Beneficiary. In preparing this Report we have not taken into account the interests, needs or circumstances of anyone apart from the Beneficiary, even though we have been aware that others might read this Report. This Report is not suitable to be relied on by any party wishing to acquire rights or assert any claims against KPMG LLP (other than the Beneficiary) for any purpose or in any context.
    [Show full text]
  • Why People Smoke
    Key Reviewer: Dr Hayden McRobbie, Consultant, Inspiring Ltd, Auckland WHY PEOPLE SMOKE 48 | BPJ | Issue 19 Supporting the PHO Performance Programme Clinicians who want to encourage people to quit smoking people around them who smoke are major influencing are likely to be more successful if they have some factors. Understanding these influencing factors is useful understanding and empathy for why people start smoking as many of them are able to be changed.3 WHY PEOPLE SMOKE and continue to smoke. This understanding and empathy is unlikely to come from experience as statistics show only It is important to ensure young people avoid starting to 3.4% of New Zealand medical practitioners are regular smoke in the first place as nicotine addiction can occur smokers and 81.4 % have never smoked.1 rapidly. In one study, 10% of children who became regular smokers showed signs of nicotine dependence within two In this article we look at what are commonly perceived by days of first inhaling from a cigarette, and 25% within a smokers as the “benefits” of smoking, along with some of month.4 Within a year of starting to smoke, it has been the more significant barriers to quitting. reported that children will be inhaling the same amount of nicotine as adults, will experience cravings when they do not smoke, will make quit attempts and will suffer Why do people start smoking? withdrawal symptoms.5 It has been estimated that 80% of adult smokers begin smoking as children, and about 30% of children have tried smoking by the age of 11.2 Why do people continue to smoke? There is no single reason why young people begin to Because of the effects of nicotine smoke.
    [Show full text]
  • Attitudes Towards Tobacco Harm Reduction Products in New Zealand Insights from the New Zealand Public and Healthcare Professionals
    Attitudes Towards Tobacco Harm Reduction Products in New Zealand Insights from the New Zealand Public and Healthcare Professionals A Report by Frost & Sullivan March 2019 CONTENTS About this 3 Report Smoking in New ENDS and Zealand Tobacco Harm 5 8 Reduction (THR) Attitudes Use of ENDS in Towards THR Tobacco Harm 10 Products 13 Reduction The Last Word Appendix: About 16 17 Our Research 2 Attitudes Towards Tobacco Harm Reduction Products in New Zealand ABOUT THIS REPORT Almost 600,000 New Zealanders still smoke, with a significantly higher smoking rate among the Māori and most economically-disadvantaged communities. In common with most developed countries, over recent many. About 60% of smokers wish to quit, but most find years the New Zealand Government has made deter- this challenging, making over six unsuccessful attempts mined efforts to reduce the national smoking rate. These on average. Adding to this is the sizeable group of smok- policies have helped to drive a significant reduction in the ers (40%) who are unwilling or unsure about quitting the incidence of smoking in the country, from around habit, either because they enjoy smoking or because one-third of the population in 1983 to less than 15% in they recognise they are addicted.6 2017/18.1 Although methods of measurement differ slightly, the rate in New Zealand parallels Australia The difficulties many smokers face in quitting and the (14.9% in 2016),2 but is ahead of all but one of the presence of a cohort of smokers unable or unwilling to European Union (EU) countries, including the United try, as well as the significant health risks associated with Kingdom (17% in 2017), Germany (25%), and France smoking, are drawing increased attention towards Tobac- (36%).3 Across the Organisation for Economic Co-opera- co Harm Reduction (THR) interventions.
    [Show full text]